MDT
96.91
-0.67%↓
A
147.87
-0.47%↓
VEEV
232.45
-3%↓
HQY
84.34
-10.55%↓
PHR.US
17.13
-0.23%↓
MDT
96.91
-0.67%↓
A
147.87
-0.47%↓
VEEV
232.45
-3%↓
HQY
84.34
-10.55%↓
PHR.US
17.13
-0.23%↓
MDT
96.91
-0.67%↓
A
147.87
-0.47%↓
VEEV
232.45
-3%↓
HQY
84.34
-10.55%↓
PHR.US
17.13
-0.23%↓
MDT
96.91
-0.67%↓
A
147.87
-0.47%↓
VEEV
232.45
-3%↓
HQY
84.34
-10.55%↓
PHR.US
17.13
-0.23%↓
MDT
96.91
-0.67%↓
A
147.87
-0.47%↓
VEEV
232.45
-3%↓
HQY
84.34
-10.55%↓
PHR.US
17.13
-0.23%↓
24h
Šī brīža
Min
Max
Ienākumi | -1.5M -6M |
|---|---|
Pārdošana | -291K 201K |
EPS | -1.14 |
Peļņas marža | -2,971.144 |
Darbinieki | 32 |
EBITDA | -1.7M -3.3M |
Nākamie ieņēmumi | 2026. g. 26. marts |
|---|
Tirgus kapitalizācija | -17M 2.1M |
|---|---|
Iepriekšējā atvēršanas cena | 0.35 |
Iepriekšējā slēgšanas cena | 0.35 |
By Trading Central
Pārliecība
Neutral Evidence
0.8417 / 0.8939 Atbalsts un pretestība
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
2026. g. 12. janv. 23:54 UTC
CBA Could Underperform Again in 2026 -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 23:48 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 23:48 UTC
Nikkei May Rise on Weaker Yen -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 23:43 UTC
Gold Edges Lower on Likely Technical Correction -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 23:18 UTC
Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com
DJ
Lasīt
2026. g. 12. janv. 21:56 UTC
Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 21:50 UTC
Health Care Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 21:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 21:18 UTC
Global Equities Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 21:18 UTC
Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 20:54 UTC
Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com
DJ
Lasīt
2026. g. 12. janv. 20:48 UTC
Oil Futures Settle Higher in Choppy Trade -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 20:33 UTC
U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 20:18 UTC
Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR
DJ
Lasīt
2026. g. 12. janv. 20:18 UTC
Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM
DJ
Lasīt
2026. g. 12. janv. 19:39 UTC
J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 19:36 UTC
Gold and Silver Set New Records on Fed Probe -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 19:36 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 19:33 UTC
Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 19:24 UTC
Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23
DJ
Lasīt
2026. g. 12. janv. 19:22 UTC
Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'
DJ
Lasīt
2026. g. 12. janv. 18:21 UTC
Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update
DJ
Lasīt
2026. g. 12. janv. 18:20 UTC
This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com
DJ
Lasīt
2026. g. 12. janv. 18:19 UTC
Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 18:16 UTC
Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 18:09 UTC
Global Equities Roundup: Market Talk
DJ
Lasīt
2026. g. 12. janv. 18:09 UTC
Baidu's Outlook Bodes Well For Shares -- Market Talk
DJ
Lasīt
2026. g. 12. janv. 18:01 UTC
QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com
DJ
Lasīt
2026. g. 12. janv. 18:00 UTC
Canada's 'Breakeven' Employment Recalibrating -- Market Talk
DJ
Lasīt
Cenas izmaiņa
By TipRanks
Neitrāls
1 ratings
0
Pirkt
1
Turēt
0
Pārdot
Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Clearside Biomedical Inc — pēdējo 3 mēnešu laikā.
By Trading Central
Īstermiņā
Neutral Evidence
The bullish and bearish events are balanced.
Vidējā termiņā
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Ilgtermiņā
Weak Bearish Evidence
There is one bearish event.
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$